.png)
Ncardia Welcomes Divisional CEO, Dr. Jeroen de Groot
Developing Next-Generation Equipment for Cell Culture Applications
Ncardia @ Neuroscience 2023: Insights & Scientific Advances
Ncardia @ ESGCT: Highlights from our week in Brussels
Ncardia and Cellistic Appoint Charles Jacques as CFO
FDA Gene Therapy Approval for Duchenne Muscular Dystrophy
Subscribe to our newsletter
Stay up to date on iPSC innovations, events and news.
